Nucleus-selective self-augmenting cascade nanoassemblies for targeted synergistic photo-chemo therapy of tumors
- 15 August 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (73) , 10940-10943
Abstract
The HPC-CAT/CL-Ap nanocomposite entered into tumor cell by endocytosis and quickly accumulate in the nucleus, thereby significantly inhibiting tumor growth and lung metastasis by self-augmenting cascade photo-chemo therapy.Keywords
Funding Information
- Chongqing University (0236011104419)
- National Natural Science Foundation of China (21877010, 82100306)
This publication has 33 references indexed in Scilit:
- Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen SpeciesNano Letters, 2017
- H2O2-Activatable and O2-Evolving Nanoparticles for Highly Efficient and Selective Photodynamic Therapy against Hypoxic Tumor CellsJournal of the American Chemical Society, 2015
- Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical FieldsChemical Reviews, 2014
- Chain‐Shattering Polymeric Therapeutics with On‐Demand Drug‐Release CapabilityAngewandte Chemie International Edition, 2013
- Nuclear-Targeted Drug Delivery of TAT Peptide-Conjugated Monodisperse Mesoporous Silica NanoparticlesJournal of the American Chemical Society, 2012
- Nuclear drug delivery for cancer chemotherapyJournal of Controlled Release, 2011
- Redox sensing: orthogonal control in cell cycle and apoptosis signallingJournal of Internal Medicine, 2010
- Role of glutathione in cell nucleusFree Radical Research, 2010
- In Vitro and In Vivo Photocytotoxicity of Boron Dipyrromethene Derivatives for Photodynamic TherapyJournal of Medicinal Chemistry, 2010
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007